Myomo Inc. (MYO) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MYO SEC filings page.
Myomo Inc. (MYO) reported $43.3M in revenue over the twelve months to Jun 30, 2026, up 6.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue scale-up is being absorbed by rising operating costs, turning improved cash conversion into renewed funding dependence.
Revenue expansion in FY2025 came with gross margin falling from71.2% in FY2024 to65.7% , so added volume did not produce operating leverage. Free-cash-flow margin then widened from-14.3% to-39.7% , linking the margin setback to materially weaker cash conversion rather than an accounting-only loss.
FY2025 SG&A plus R&D reached
Operating cash flow of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Myomo Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Myomo Inc. held $18.4M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $14.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Myomo Inc. scores 39/100 among other emerging companies.
Myomo Inc. had 39M shares outstanding at the end of fiscal year 2025, against 34M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Myomo Inc. scores 40/100 among other emerging companies.
Myomo Inc. spent $6.9M on research and development in fiscal year 2025, which was 12.5% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Myomo Inc. scores 40/100 among other emerging companies.
Myomo Inc. reported revenue of $40.9M in fiscal year 2025, against $32.6M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Myomo Inc. scores 78/100 among other emerging companies.
Myomo Inc.'s operations used $14.5M of cash in fiscal year 2025, against $3.3M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Myomo Inc. scores 15/100 among other emerging companies.
Myomo Inc.'s cash, cash equivalents and investments came to $18.4M at the end of fiscal year 2025, against $27.2M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Myomo Inc. scores 50/100 among other emerging companies.
Myomo Inc. scores -2.45, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($64.6M) relative to total liabilities ($27.2M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Myomo Inc. passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Myomo Inc. reported a net loss of $15.6M while operations used $14.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Myomo Inc. reported an operating loss of $14.4M against $451K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Myomo Inc. generated $11.7M in revenue in Q2 2026. This represents an increase of 21.3% from the same quarter a year earlier. Against the prior quarter it is up 15.7%.
Myomo Inc.'s EBITDA was -$1.9M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 57.5% from the same quarter a year earlier. Against the prior quarter it is up 34.7%.
Myomo Inc. reported -$4.0M in net income in Q2 2026. This represents an increase of 13.2% from the same quarter a year earlier. Against the prior quarter it is down 33.6%.
Myomo Inc. earned -$0.09 per diluted share (EPS) in Q2 2026. This represents an increase of 18.2% from the same quarter a year earlier. Against the prior quarter it is down 28.6%.
Cash & Balance Sheet
Myomo Inc. recorded an outflow of $2.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 78.2% from the same quarter a year earlier. Against the prior quarter it is up 21.7%.
Myomo Inc. held $11.2M in cash against $11.5M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Myomo Inc.'s gross margin was 72.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 9.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.9 percentage points.
Myomo Inc.'s operating margin was -19.3% in Q2 2026, reflecting core business profitability. This is up 28.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.0 percentage points.
Myomo Inc.'s net profit margin was -34.4% in Q2 2026, showing the share of revenue converted to profit. This is up 13.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.6 percentage points.
Myomo Inc.'s ROE was -69.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 42.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 35.5 percentage points.
Capital Allocation
Myomo Inc. invested $1.7M in research and development in Q2 2026. This represents a decrease of 14.0% from the same quarter a year earlier. Against the prior quarter it is up 6.0%.
Myomo Inc. invested $32K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 85.4% from the same quarter a year earlier. Against the prior quarter it is down 90.1%.
Not reported for Q2 2026.
MYO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.7M+21.3% | $10.1M+2.9% | $11.4M-5.9% | $10.1M+9.6% | $9.7M+28.3% | $9.8M+161.9% | $12.1M+153.7% | $9.2M+81.3% |
| Cost of Revenue | $73K+21.1% | $60K+84.0% | -$81K+65.8% | $98K-26.5% | $60K-50.6% | $32K-71.1% | -$237K+82.7% | $133K+304.3% |
| Gross Profit | $8.4M+39.5% | $6.9M+4.4% | $7.8M-9.6% | $6.4M-7.2% | $6.1M+13.6% | $6.6M+187.5% | $8.6M+177.5% | $6.9M+99.1% |
| R&D Expenses | $1.7M-14.0% | $1.6M-9.3% | $1.6M+4.2% | $1.5M+22.3% | $2.0M+98.7% | $1.8M+87.2% | $1.6M+77.6% | $1.2M+74.1% |
| SG&A Expenses | $3.7M+9.0% | $3.6M-8.2% | $3.4M-4.8% | $3.2M-2.3% | $3.4M+28.3% | $3.9M+37.4% | $3.6M-22.7% | $3.3M-32.2% |
| Operating Income | -$2.3M+50.9% | -$3.2M+10.3% | -$2.8M-1030.7% | -$3.5M-267.3% | -$4.6M-311.7% | -$3.5M+9.5% | -$245K+89.9% | -$958K+52.7% |
| EBITDA | -$1.9M+57.5% | -$2.9M+14.8% | N/A | N/A | -$4.4M-334.0% | -$3.4M+11.5% | $221K+109.4% | -$836K+55.9% |
| Interest Expense | $536K | $505K | N/A | $10K | N/A | N/A | N/A | N/A |
| Income Tax | $31K-78.8% | $187K+36.5% | $84K-1.1% | $136K+59.8% | $148K+30.2% | $137K+66.5% | $85K+19.8% | $85K+83.1% |
| Net Income | -$4.0M+13.2% | -$3.0M+13.2% | -$3.8M-1289.6% | -$3.7M-279.0% | -$4.6M-313.0% | -$3.5M+9.7% | -$276K+88.5% | -$966K+52.4% |
| EPS (Basic) | -$0.09+18.2% | -$0.07+12.5% | -$0.09 | -$0.09-200.0% | -$0.11-266.7% | -$0.08+20.0% | $0.00+100.0% | -$0.03+50.0% |
| EPS (Diluted) | -$0.09+18.2% | -$0.07+12.5% | -$0.09 | -$0.09-200.0% | -$0.11-266.7% | -$0.08+20.0% | $0.00+100.0% | -$0.03+50.0% |
| Diluted Shares (Avg) | 43M+2.7% | 42M+2.0% | N/A | 42M+11.1% | 42M+11.3% | 41M+12.8% | N/A | 38M+7.6% |
MYO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $35.3M-8.6% | $36.8M-10.1% | $38.6M-8.5% | $34.1M+108.9% | $38.7M+138.9% | $40.9M+147.4% | $42.2M+189.7% | $16.3M-4.3% |
| Current Assets | $24.5M-12.5% | $25.7M-17.5% | $27.6M-16.0% | $22.9M+56.1% | $28.0M+85.2% | $31.1M+98.0% | $32.8M+140.2% | $14.7M-8.3% |
| Cash & Equivalents | $11.2M-21.2% | $11.4M-42.4% | $14.1M-42.0% | $12.6M+89.6% | $14.2M+143.6% | $19.8M+264.2% | $24.4M+254.7% | $6.6M-4.2% |
| Short-Term Investments | $2.2M+79.9% | $4.3M0.0% | $4.3M+764.5% | $0 | $1.2M-60.4% | $4.3M-22.2% | $493K-75.3% | $0-100.0% |
| Inventory | $3.2M-23.2% | $3.5M+5.3% | $3.1M-1.4% | $3.6M+7.7% | $4.1M+58.6% | $3.4M+41.1% | $3.2M+75.5% | $3.4M+127.9% |
| Accounts Receivable | $4.9M-29.9% | $4.8M+3.5% | $4.1M+7.1% | $5.3M+41.9% | $7.1M+179.2% | $4.7M+177.0% | $3.8M+60.5% | $3.7M+48.2% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $29.5M+40.2% | $27.8M+44.7% | $27.2M+55.4% | $19.5M+177.1% | $21.1M+223.3% | $19.2M+241.2% | $17.5M+213.5% | $7.0M+16.4% |
| Current Liabilities | $10.6M-9.7% | $9.4M-19.6% | $8.3M-18.0% | $9.2M+31.6% | $11.8M+81.8% | $11.7M+110.1% | $10.2M+85.7% | $7.0M+21.0% |
| Non-Current Liabilities | $18.9M+103.2% | $18.4M+144.7% | $18.9M+156.7% | $10.2M+35042.8% | $9.3M+19553.2% | $7.5M+11517.8% | $7.4M+6289.5% | $29K-88.5% |
| Long-Term Debt | $11.5M+764.9% | $10.9M | $11.2M0.0% | $2.4M | $1.3M | N/A | $11.2M | N/A |
| Total Equity | $5.8M-66.9% | $9.0M-58.5% | $11.4M-53.9% | $14.6M+57.4% | $17.6M+82.0% | $21.7M+99.0% | $24.7M+174.9% | $9.3M-15.7% |
| Retained Earnings | -$125.7M-13.0% | -$121.7M-14.2% | -$118.7M-15.1% | -$114.9M-11.7% | -$111.2M-9.2% | -$106.6M-5.8% | -$103.1M-6.4% | -$102.9M-8.9% |
Not reported in any period shown, so not listed: Goodwill.
MYO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.9M+78.1% | -$2.2M+17.9% | -$1.1M-133.9% | -$1.8M-22.4% | -$8.9M-362.7% | -$2.7M+17.5% | $3.4M+242.9% | -$1.5M+12.9% |
| Depreciation & Amortization | $385K+101.5% | $292K+84.0% | $454K-2.5% | N/A | $191K+88.2% | $158K+79.3% | $466K+481.0% | $121K-4.7% |
| Stock-Based Compensation | $1.0M+164.0% | $597K+10.6% | N/A | $584K+80.1% | $395K+529.7% | $540K+68.7% | N/A | $324K-1.9% |
| Capital Expenditures | $32K-85.4% | $328K-51.1% | -$1.2M+44.0% | $2.1M+551.3% | $221K+85.6% | $671K+1021.4% | $860K+2616.7% | $321K+492.9% |
| Free Cash Flow | -$2.0M+78.2% | -$2.5M+24.6% | -$2.4M-195.0% | -$3.9M-115.9% | -$9.1M-346.5% | -$3.3M-1.3% | $2.5M+204.9% | -$1.8M-2.6% |
| Investing Cash Flow | $2.0M+367.0% | -$494K+73.9% | -$4.6M-239.5% | $190K-93.3% | -$757K-132.5% | -$1.9M+46.5% | -$1.4M-159.0% | $2.8M+314.8% |
| Financing Cash Flow | -$244K-106.1% | $0+100.0% | $7.5M-52.4% | -$50K+74.9% | $4.0M | -$37K-100.7% | $15.8M+50870932.3% | -$200K-105.1% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
MYO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.1%+9.4pp | 68.2%+1.0pp | 68.6%-2.8pp | 63.8%-11.6pp | 62.7%-8.1pp | 67.2%+6.0pp | 71.4%+6.1pp | 75.4%+6.8pp |
| Operating Margin | -19.3%+28.3pp | -31.2%+4.6pp | -24.4%-22.4pp | -34.9%-24.5pp | -47.6%-32.7pp | -35.8% | -2.0%+49.1pp | -10.4%+29.5pp |
| Net Margin | -34.4%+13.6pp | -29.8%+5.5pp | -33.8%-31.5pp | -36.3%-25.8pp | -48.0%-33.1pp | -35.2% | -2.3%+48.4pp | -10.5%+29.5pp |
| Return on Equity | -69.0%-42.7pp | -33.4%-17.4pp | -33.7%-32.6pp | -25.0%-14.6pp | -26.3%-14.7pp | -16.0%+19.2pp | -1.1%+25.7pp | -10.4%+8.0pp |
| Return on Assets | -11.4%+0.6pp | -8.2%+0.3pp | -9.9%-9.3pp | -10.8%-4.8pp | -12.0%-5.1pp | -8.5%+14.7pp | -0.7%+15.9pp | -5.9%+6.0pp |
| Current Ratio | 2.31-0.1x | 2.73+0.1x | 3.30+0.1x | 2.49+0.4x | 2.390.0x | 2.66-0.2x | 3.22+0.7x | 2.10-0.7x |
| Debt-to-Equity | 1.98+1.9x | 1.21+0.3x | 0.98+0.5x | 0.17-0.6x | 0.08-0.6x | 0.88+0.4x | 0.45-0.2x | 0.76+0.2x |
| Asset Turnover | 0.33+0.1x | 0.280.0x | 0.290.0x | 0.30-0.3x | 0.25-0.2x | 0.240.0x | 0.290.0x | 0.56+0.3x |
| FCF Margin | -16.9%+77.3pp | -25.0%+9.1pp | -21.0%-41.7pp | -38.8%-19.1pp | -94.1%-67.1pp | -34.1%+54.0pp | 20.8%+71.0pp | -19.7%+15.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Myomo Inc. MYO | FY2025 | $40.9M | -$15.6M | -38.1% | $64.6M | 44/100 |
| Inspira Technologies Oxy B.H.N. Ltd. IINN | FY2025 | $289K | -$13.2M | N/A | $16.2M | — |
| VICARIOUS SRGCL INC A RBOT | FY2025 | N/A | -$50.2M | N/A | $13.7M | — |
| electroCore, Inc. ECOR | FY2025 | $32.0M | -$14.0M | -43.6% | $91.4M | 45/100 |
| NeuroOne Medical Technologies Corporation NMTC | FY2025 | $9.1M | -$3.6M | -39.6% | $10.2M | 64/100 |
| Modular Medical, Inc. MODD | FY2026 | N/A | -$28.2M | N/A | $16.5M | — |
Where Myomo Inc. Ranks
Frequently Asked Questions
What is Myomo Inc.'s annual revenue?
Myomo Inc. (MYO) reported $40.9M in total revenue for fiscal year 2025. This represents a 25.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Myomo Inc.'s revenue growing?
Myomo Inc. (MYO) revenue grew by 25.7% year-over-year, from $32.6M to $40.9M in fiscal year 2025.
Is Myomo Inc. profitable?
No, Myomo Inc. (MYO) reported a net income of -$15.6M in fiscal year 2025, with a net profit margin of -38.1%.
What is Myomo Inc.'s EBITDA?
Myomo Inc. (MYO) had EBITDA of -$12.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Myomo Inc. have?
As of fiscal year 2025, Myomo Inc. (MYO) had $14.1M in cash and equivalents against $11.2M in long-term debt.
What is Myomo Inc.'s gross margin?
Myomo Inc. (MYO) had a gross margin of 65.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Myomo Inc.'s operating margin?
Myomo Inc. (MYO) had an operating margin of -35.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Myomo Inc.'s net profit margin?
Myomo Inc. (MYO) had a net profit margin of -38.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Myomo Inc.'s return on equity (ROE)?
Myomo Inc. (MYO) has a return on equity of -136.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Myomo Inc.'s free cash flow?
Myomo Inc. (MYO) recorded an outflow of $16.3M in free cash flow during fiscal year 2025. This represents a -249.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Myomo Inc.'s operating cash flow?
Myomo Inc. (MYO) recorded an outflow of $14.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Myomo Inc.'s total assets?
Myomo Inc. (MYO) had $38.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Myomo Inc.'s capital expenditures?
Myomo Inc. (MYO) invested $1.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Myomo Inc. spend on research and development?
Myomo Inc. (MYO) invested $6.9M in research and development during fiscal year 2025.
What is Myomo Inc.'s current ratio?
Myomo Inc. (MYO) had a current ratio of 3.30 as of fiscal year 2025, which is generally considered healthy.
What is Myomo Inc.'s debt-to-equity ratio?
Myomo Inc. (MYO) had a debt-to-equity ratio of 0.98 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Myomo Inc.'s return on assets (ROA)?
Myomo Inc. (MYO) had a return on assets of -40.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Myomo Inc.'s P/E ratio?
Myomo Inc. (MYO) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $64.6M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Myomo Inc.'s price-to-sales ratio?
Myomo Inc. (MYO) trades at 1.5x sales, its market capitalization divided by revenue of $43.3M revenue, trailing 12 months to June 30, 2026. The market capitalization is $64.6M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Myomo Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Myomo Inc. (MYO) held $18.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $14.5M over that year. Dividing the one by the other, the reported balance equals about 15 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Myomo Inc.'s Altman Z-Score?
Myomo Inc. (MYO) has an Altman Z-Score of -2.45, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Myomo Inc.'s Piotroski F-Score?
Myomo Inc. (MYO) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Myomo Inc.'s earnings high quality?
Myomo Inc. (MYO) reported a net loss of $15.6M while operations used $14.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Myomo Inc. cover its interest payments?
Myomo Inc. (MYO) reported an operating loss of $14.4M against $451K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Myomo Inc.?
Myomo Inc. (MYO) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.